Dr. Mahipal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of ConnecticutResidency, Internal Medicine, 2005 - 2008
- Maulana Azad Medical CollegeClass of 2003, MBBS
Certifications & Licensure
- OH State Medical License 2022 - 2026
- FL State Medical License 2011 - 2023
- MN State Medical License 2016 - 2022
- PA State Medical License 2008 - 2012
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Start of enrollment: 2011 Jun 20
- Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects Start of enrollment: 2011 Oct 01
- Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma.Shruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, Kari G Rabe, Amit Mahipal
Endocrine-Related Cancer. 2025-04-01 - Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment.Veronica Mears, Nikolas Naleid, Omkar Pawar, Jennifer Eva Selfridge, Madison Conces
JCO Oncology Practice. 2025-03-04 - 1 citationsSWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Canc...Rachna T Shroff, Gentry King, Sarah Colby, Aaron J Scott, Mitesh J Borad
Journal of Clinical Oncology. 2025-02-10
Journal Articles
- Systemic Therapy and Sequencing Options in Advanced Hepatocellular CarcinomaMohamad Bassam Sonbol, Amit Mahipal, Zhaohui Jin, Kabir Mody, Mitesh J Borad, Daniel H Ahn, Tanios Bekaii-Saab, JAMA Oncology
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerOlatunji B Alese, Daneng Li, Amit Mahipal, JAMA Oncology
Authored Content
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020
Press Mentions
- Using a Person's Own Immune System to Fight Cancer: Phase I Clinical Trial of New Immunotherapy BeginningApril 10th, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: